A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection

Cell Growth and Differentiation

Volumn 10, Issue 12, 1999, Pages 829-838

  Zhu, Jing W ^a   DeRyckere, Deborah ^a   Li, Feng X ^a   Wan, Yisong Y ^a   DeGregori, James ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; DNA DAMAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; ANTIGENS, VIRAL; APOPTOSIS; CARRIER PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL CYCLE PROTEINS; DEXAMETHASONE; DNA DAMAGE; DNA-BINDING PROTEINS; DOXORUBICIN; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTEIN BIOSYNTHESIS; RECEPTORS, ANTIGEN, T-CELL; RETROVIRIDAE; SUPERANTIGENS; THYMUS GLAND; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 0033450933     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Nossal, G. J. V. Negative selection of lymphocytes. Cell, 76: 229-239, 1994.
2. Weiss, A., and Littman, D. R. Signal transduction by lymphocyte antigen receptors. Cell, 76: 263-274, 1994.
3. Io thymocytes in vivo. Science (Washington DC), 250: 1720-1723, 1990.
4. Delovitch, T. L., and Singh, B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity, 7: 727-738, 1997.
5. Dyson, N. The regulation of E2F by pRB-family proteins. Genes Dev., 12: 2245-2262, 1998.
6. DeGregori, J., Leone, G., Miron, A., Jakoi, L., and Nevins, J. R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA, 94: 7245-7250, 1997.
7. Field, S. J., Tsai, F-Y., Kuo, F., Zubiaga, A. M., Kaelin, W. G., Jr., Livingston, D. M., Orkin, S. H., and Greenberg, M. E. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell, 85: 549-561, 1996.
8. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E., and Dyson, N. J. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell, 85: 537-548, 1996.
9. Shi, Y., Bissonnette, R. P., Parfrey, N., Szalay, M., Kubo, R. T., and Green, D. R. In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes. J. Immunol., 146: 3340-3346, 1991.
10. Wu, X., and Levine, A. J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA, 91: 3602-3606, 1994.
11. Kowalik, T. F., DeGregori, J., Schwarz, J. K., and Nevins, J. R. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol., 69: 2491-2500, 1995.
12. Shan, B., and Lee, W-H. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol., 14: 8166-8173, 1994.
13. Qin, X-Q., Livingston, D. M., Kaelin, W. G., and Adams, P. D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 91: 10918-10922, 1994.
14. Hsieh, J. K., Fredersdorf, S., Kouzarides, T., Martin, K., and Lu, X. E2F1 -induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev., 11: 1840-1852, 1997.
15. Phillips, A. C., Bates, S., Ryan, K. M., Helin, K., and Vousden, K. H. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev., 11: 1853-1863, 1997.
16. Ko, L. J., and Prives, C. p53: puzzle and paradigm. Genes Dev., 10: 1054-1072, 1996.
17. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
18. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993.
19. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
20. de Stanchina, E., McCurrach, M. E., Zindy, F., Shieh, S. Y., Ferbeyre, G., Samuelson, A. V., Prives, C., Roussel, M. F., Sherr, C. J., and Lowe, S. W. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev., 12: 2434-2442, 1998.
21. Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., and Roussel, M. F. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev., 12: 2424-2433, 1998.
22. Quelle, D. E., Zindy, F., Ashmun, R. A., and Sherr, C. J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 83: 993-1000, 1995.
23. Ruas, M., and Peters, G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta, 1378: F115-F177, 1998.
24. Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., and Vousden, K. H. p14ARF links the tumour suppressors RB and p53. Nature (Lond.), 395: 124-125, 1998.
25. Robertson, K. D., and Jones, P. A. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol. Cell. Biol., 18: 6457-6473, 1998.
26. Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., and Sherr, C. J. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. USA, 95: 8292-8297, 1998.
27. Stott, F. J., Bates, S., James, M. C., McConnell, B. B., Starborg, M., Brookes, S., Palmero, I., Ryan, K., Hara, E., Vousden, K. H., and Peters, G. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J., 17: 5001-5014, 1998.
28. Pomerantz, J., Schreiber-Agus, N., Liegeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H. W., Cordon-Cardo, C., and DePinho, R. A. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell, 92: 713-723, 1998.
29. Honda, R., and Yasuda, H. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J., 18: 22-27, 1999.
30. Zhang, Y., and Xiong, Y. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Molecular Cell., 3: 579-591, 1999.
31. Tao, W., and Levine, A. J. P19(ARF) stabilizes p53 by blocking nucleocytoplasmic shuttling of Mdm2. Proc. Natl. Acad. Sci. USA, 96: 6937-6941, 1999.
32. Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., and Bar-Sagi, D. Nucleolar Arf sequesters Mdm2 and activates p53. Nature Cell Biology, 1: 20-26, 1999.
33. von Boehmer, H. Developmental biology of T cells in T cell-receptor transgenic mice. Annu. Rev. Immunol., 8: 531-556, 1990.
34. +, double-positive stage. J. Exp. Med., 184: 1619-1630, 1996.
35. Shinkai, Y., Rathbun, G., Lam, K. P., Oltz, E. M., Stewart, V., Mendelsohn, M., Charron, J., Datta, M., Young, F., Stall, A. M., et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell, 68: 855-867, 1992.
36. Oettinger, M. A. Cutting apart V(D)J recombination. Curr. Opin. Genet. Dev., 6: 141-145, 1996.
37. Sette, A., Buus, S., Colon, S., Smith, J. A., Miles, C., and Grey, H. M. Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells. Nature (Lond.), 328: 395-399, 1987.
38. Castro, J. E., Listman, J. A., Jacobson, B. A., Wang, Y., Lopez, P. A., Ju, S., Finn, P. W., and Perkins, D. L. Fas modulation of apoptosis during negative selection of thymocytes. Immunity, 5: 617-627, 1996.
39. Scherer, M. T., Ignatowicz, L., and Winslow, G. M. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu. Rev. Cell Biol., 9: 101-128, 1993.
40. Kappler, J. W., Roehm, N., and Marrack, P. C. T cell tolerance by clonal elimination in the thymus. Cell, 149: 273-280, 1987.
41. a-encoded antigens. Nature (Lond.), 332: 40-45, 1988.
42. Foy, T. M., Page, D. M., Waldschmidt, T. J., Schoneveld, A., Laman, J. D., Masters, S. R., Tygrett, L., Ledbetter, J. A., Aruffo, A., Claassen, E., Xu, J. C., Flavell, R. A., Oehen, S., Hedrick, S. M., and Noelle, R. J. An essential role for gp39, the ligand for CD40, in thymic selection. J. Exp. Med., 182: 1377-1388, 1995.
43. Martin, S. J., Reutelingsperger, C. P., McGahon, A. J., Rader, J. A., van Schie, R. C., LaFace, D. M., and Green, D. R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med., 182: 1545-1556, 1995.
44. Hiebert, S. W., Packham, G., Strom, D. K., Haffner, R., Oren, M., Zambetti, G., and Cleveland, J. L. E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol. Cell. Biol., 15: 6864-6874, 1995.
45. Kowalik, T. F., DeGregori, J., Leone, G., Jakoi, L., and Nevins, J. R. E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. Cell Growth Differ., 9: 113-118, 1998.
46. Sherr, C. J. Tumor surveillance via the ARF-p53 pathway. Genes Dev., 12: 2984-2991, 1998.
47. Hoffman, E. S., Passoni, L., Crompton, T., Leu, T. M., Schatz, D. G., Koff, A., Owen, M. J., and Hayday, A. C. Productive T-cell receptor β-chain gene rearrangement: coincident regulation of cell cycle and clonality during development in vivo. Genes Dev., 10: 948-962, 1996.
48. Zong, W. X., Edelstein, L. C., Chen, C., Bash, J., and Gelinas, C. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev., 13: 382-387, 1999.
49. Grumont, R. J., Rourke, I. J., and Gerondakis, S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev., 13: 400-411, 1999.
50. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80: 293-299, 1995.
51. Inoue, K., Roussel, M. F., and Sherr, C. J. Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1. Proc. Natl. Acad. Sci. USA, 96: 3993-3398, 1999.
52. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
53. Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., and Sherr, C. J. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell, 91: 649-659, 1997.
54. Hakem, A., Sasaki, T., Kozieradzki, I., and Penninger, J. M. The cyclin-dependent kinase Cdk2 regulates thymocyte apoptosis. J. Exp. Med., 189: 957-968, 1999.
55. Chiarle, R., Podda, A., Prolla, G., Podack, E. R., Thorbecke, G. J., and Inghirami, G. CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a bcl-2-sensitive pathway. J. Immunol., 163: 194-205, 1999.
56. Kishimoto, H., Surh, C. D., and Sprent, J. A role for Fas in negative selection of thymocytes in vivo. J. Exp. Med., 187: 1427-1438, 1998.
57. Amakawa, R., Hakem, A., Kundig, T. M., Matsuyama, T., Simard, J. J. L., Timms, E., Wakeham, A., Mittruecker, H-W., Griesser, H., Takimoto, H., Schmits, R., Shahinian, A., Ohashi, P. S., Penninger, J. M., and Mak, T. W. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell, 84: 551-562, 1996.
58. Patarca, R., Wei, F. Y., Iregui, M. V., and Cantor, H. Differential induction of interferon y gene expression after activation of CD4+ T cells by conventional antigen and MIs superantigen. Proc. Natl. Acad. Sci. USA, 88: 2736-2739, 1991.
59. Liu, H., Lampe, M. A., Iregui, M. V., and Cantor, H. Conventional antigen and superantigen may be coupled to distinct and cooperative T-cell activation pathways. Proc. Natl. Acad. Sci. USA, 88: 8705-8709, 1991.
60. Calnan, B. J., Szychowski, S., Chan, F. K-M., Cado, D., and Winoto, A. A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity, 3: 273-282, 1995.
61. Hettmann, T., DiDonato, J., Karin, M., and Leiden, J. M. An essential role for nuclear factor KB in promoting double positive thymocyte apoptosis. J. Exp. Med., 189: 145-158, 1999.
62. + thymocytes. J. Immunol., 151: 1868-1880, 1993.
63. Aiba, Y., Mazda, O., Davis, M. M., Muramatsu, S., and Katsura, Y. Requirement of a second signal from antigen presenting cells in the clonal deletion of immature T cells. Int. Immunol., 6: 1475-1483, 1994.
64. Kishimoto, H., and Sprent, J. Several different cell surface molecules control negative selection of medullary thymocytes. J. Exp. Med., 190: 65-73, 1999.
65. Page, D. M., Roberts, E. M., Peschon, J. J., and Hedrick, S. M. TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection. J. Immunol., 160: 120-133, 1998.
66. Sebzda, E., Mariathasan, S., Ohteki, T., Jones, R., Bachmann, M. F., and Ohashi, P. S. Selection of the T cell repertoire. Annu. Rev. Immunol., 17: 829-874, 1999.
67. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature (Lond.), 356: 215-221, 1992.
68. Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., and Weinberg, R. A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol., 4: 1-7, 1994.
69. Yamasaki, L., Bronson, R., Williams, B. O., Dyson, N. J., Harlow, E., and Jacks, T. Loss of E2F-1 reduces tumorigenesis and extends the life span of Rb1(+/-) mice. Nat. Genet., 18: 360-364, 1998.
70. Pan, H., Yin, C., Dyson, N. J., Harlow, E., Yamasaki, L., and Van Dyke, T. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Molecular Cell., 2: 283-292, 1998.
71. Tsai, K. Y., Hu, Y., Macleod, K. F., Crowley, D., Yamasaki, L., and Jacks, T. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Molecular Cell., 2: 293-304, 1998.
72. Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., and Berns, A. Simplified mammalian DNA isolation procedure. Nucleic Acids Res., 19: 4293, 1991.